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Abstract
Background: Obesity has been hypothesized to be associated with reduced moderate-to-vigorous physical activity
(MVPA) and increased sedentary time (ST). It is important to assess whether, and the extent to which, levels
of MVPA and ST are suboptimal among children and adolescents with obesity. The primary objective of this
study was to examine accelerometer-measured time spent in MVPA and ST of children and adolescents with
obesity, compared with MVPA recommendations, and with non-obese peers.
Methods: An extensive search was carried out in Medline, Cochrane library, EMBASE, SPORTDiscus, and CINAHL, from
2000 to 2015. Study selection and appraisal: studies with accelerometer-measured MVPA and/or ST (at least 3 days and
6 h/day) in free-living obese children and adolescents (0 to 19 years) were included. Study quality was assessed formally.
Meta-analyses were planned for all outcomes but were precluded due to the high levels of heterogeneity across
studies. Therefore, narrative syntheses were employed for all the outcomes.
Results: Out of 1503 records, 26 studies were eligible (n = 14,739 participants; n = 3523 with obesity); 6/26 studies
involved children aged 0 to 9 years and 18/26 involved adolescents aged 10.1 to19 years. In the participants with
obesity, the time spent in MVPA was consistently below the recommended 60 min/day and ST was generally high
regardless of the participant’s age and gender. Comparison with controls suggested that the time spent in MVPA was
significantly lower in children and adolescents with obesity, though differences were relatively small. Levels of MVPA in
the obese and non-obese were consistently below recommendations. There were no marked differences in ST between
obese and non-obese peers.
Conclusions: MVPA in children and adolescents with obesity tends to be well below international recommendations.
Substantial effort is likely to be required to achieve the recommended levels of MVPA among obese individuals in
obesity treatment interventions.
This systematic review has been registered on PROSPERO (International Database of Prospective Register Systematic
Reviews; registration number CRD42015026882).
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Background
The prevalence of obesity among children and adoles-
cents is now very high in both developing and developed
countries [1, 2] and is a significant public health and
clinical concern [3] that is attracting much research at-
tention [4]. Obesity is known to have a significant im-
pact on both physical and psychological health and
children and adolescents with obesity face a number of
health, social, and psychological problems [2, 5, 6]. Pre-
vention of childhood obesity is a public health priority
while treatment is becoming an increasingly important
clinical issue.
A number of health behaviors have been associated
with risk of obesity [7]. Poor diet, lack of physical ac-
tivity (PA) and increased sedentary time (ST) have
been linked to the development and maintenance of
childhood and adolescent obesity [8–11]. Many
evidence-based guidelines focusing on the amount of
PA, particularly moderate–to-vigorous intensity phys-
ical activity (MVPA) required to produce health bene-
fits, have been developed. These guidelines commonly
recommend 60 min of MVPA as a daily minimum
(7 days a week) for school-age children and adoles-
cents [12–15].
Accelerometry currently represents the most accurate,
inexpensive, and reliable method for objectively measur-
ing both the amount and intensity of PA and amount of
sedentary behavior (SB) [16, 17]. There have been many
surveys and studies on the levels and adequacy of MVPA
in healthy-weight children and adolescents [18, 19].
Since MVPA and ST are also important to health in
those with obesity, and since obesity has been hypothe-
sized to be associated with reduced MVPA [20] these
variables need to be reviewed for children and adoles-
cents with obesity. Whether and to what extent obesity
in childhood and adolescence is associated with reduced
objectively measured MVPA and ST/SB remains unclear,
in part because of the lack of a synthesis of the evidence
on this topic. Many studies have addressed the topic
using subjective measurement methods, and/or consid-
ering the overweight as obese, and/or focusing on total
volume of physical activity rather than MVPA. It is im-
portant to assess objectively measured time spent in
MVPA and ST in children and adolescents with obesity.
The primary aim of the present systematic review was
therefore to determine obese children’s and adolescents’
habitual amount of time spent in MVPA, and examine
whether those living with obesity met the current MVPA
recommendation for health of a minimum of 60 min per
day [14, 21]. Secondary aims were to examine time spent
in accelerometer-measured SB by children and adoles-
cents with obesity, and to determine whether MVPA
and ST in obese children and adolescents were different
from the non-obese peers.
Methods
Registration of systematic reviews
This systematic literature review was performed in ac-
cordance with the Preferred Reporting Items for System-
atic Reviews (PRISMA) guidelines [22]. The review
protocol was registered on PROSPERO (registration
number CRD42015026882), the international prospect-
ive register for systematic reviews (http://www.crd.yor-
k.ac.uk/ NIHR_PROSPERO).
Literature search
The literature search was conducted searching for Eng-
lish language peer-reviewed studies using the five most
relevant electronic databases from 2000 up to March
2015 (accelerometry became more widely used in re-
search from the early 2000’s): MEDLINE OVID;
Cochrane library; EMBASE; SPORTSDiscus and
CINAHL by AM. The literature search in the Cochrane
Central Register of Controlled Trials is shown in Table 1,
and was adapted as required for the other databases. Full
literature search details are available from the
corresponding author on request. The electronic search
was complemented by reference citation tracking (for-
ward and backward) of the included studies and of pre-
vious reviews.
Inclusion criteria
To be eligible for inclusion in the review, papers had to
meet all of the following criteria as per the PICOS prin-
ciples: Population: children and adolescents aged from 0
to 19 years as defined by the WHO; Intervention or ex-
posure: children or adolescent classified as obese. Obes-
ity had to be defined using an acceptable objective
method, e.g. defined as having a body mass index
(BMI) ≥ 95th percentile for children of the same sex and
age, or defined as the equivalent of 30 kg/m2 Inter-
national Obesity Task Force (IOTF definition), or de-
fined as obese relative to World Health Organization
(WHO) BMI for age and sex charts; Comparison: habit-
ual amount of time spent in MVPA and/or ST of non-
obese children and adolescents; Outcomes: habitual
amount of time spent in MVPA and/or ST measured by
accelerometer and reported in the form of minutes/day
of MVPA or ST; MVPA and its relationship to the
60 min/day recommended. All study designs were con-
sidered eligible: cross-sectional, longitudinal, case-
control studies and intervention studies were eligible if
pre-intervention data could be extracted.
Exclusion criteria
We excluded studies that included only overweight par-
ticipants, combined overweight and obese groups, or in-
cluded participants with any known barrier or limitation
to physical activity (e.g. physical disability). Studies that
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used subjective methods, objective (e.g. doubly labelled
water) or direct observation methods apart from acceler-
ometer measurements were excluded.
Since the aim of the review was to examine habitual
levels of MVPA and ST, studies that measured these var-
iables for less than 6 h per day or over 2 days or less
were excluded. Recommendations currently exist for ha-
bitual (overall) MVPA rather than MVPA during specific
domains (e.g. the after school period) and so studies that
focused only on specific periods of the day (e.g. school
activity only, or outdoor activity only, or weekend activ-
ity only, or weekday activity only, or after-school only)
were also excluded. A detailed description of the eligibil-
ity criteria is given in [Additional file 1].
Study selection
Titles, abstracts, and full-text articles were screened in
duplicate for eligibility by RE and JYP and disagreements
were resolved through discussions with other reviewers
when required. Reference lists of eligible studies were
examined for potentially eligible studies, and studies that
cited eligible studies were identified and tested for eligi-
bility. The reviewers were not blinded to authors or
journal of publication. Reasons for exclusion are sum-
marised in the study flow diagram (Fig. 1) and available
in details from the corresponding author on request.
Data extraction
A standardised data extraction form was used to popu-
late the evidence tables by RE and repeated by JJR and
JYP. The extracted items were: first author, publication
year, country, study design, sample group, comparison
group-if applicable, accelerometer type, cut points for
MVPA and ST, finding of MVPA (minutes/day) and ST
(minutes/day or %) data, summary and author conclu-
sions. International recommendations are usually for the
achievement of at least 60 min of MVPA every day, but
in the eligible studies the achievement of MVPA recom-
mendations was never operationalised in this way. In
most studies that referred to the achievement of MVPA
recommendations, the mean or median daily MVPA
(minutes/day) was provided, and so this was used as a
proxy for achievement of recommendations in the
present study.
Data analysis and synthesis
We considered the data for meta-analysis but identified
a substantial level of statistical heterogeneity between
the studies (I2 statistic > 70%) that led to the decision
not to present the combined results of individual studies.
Hence, we performed a narrative synthesis of the data
and present the findings in tabular, textual and graphical
form. Data were synthesised by the age and sex of the
subgroups as those are factors known to be strongly as-
sociated with both the exposure variable, obesity, and
the outcomes, MVPA and ST, and so might explain
some of the observed findings. The age subgroup was
categorised according to the WHO definition of children
and adolescence, i.e. as children aged 0 to 9.9 years old
and adolescents aged 10.1 to 19 years old. Data for boys,
girls and mixed-sex studies are reported separately
where possible.
Quality assessment
Eligible articles were assessed for methodological quality
using a 15-item quality assessment scale as shown in
[Additional file 2], collapsed to 6 items for scoring, with
higher scores suggesting higher study quality. Each eli-
gible study was assessed by RE, and disagreements were
resolved by discussion with JJR and JYP. The quality as-
sessment scale was modified from the methodological
quality assessment scale of Tooth et al. [23]. This is a
Table 1 Search strategy of Cochrane Central Register of
Controlled Trials
. #1 MeSH descriptor: [Child] explode all trees
. #2 MeSH descriptor: [Adolescent] explode all trees
. #3 child* or adolesc* or teen* or boy* or girl* or youth:ti,ab,kw
(Word variations have been searched)
. #4 young near/1 (person or people):ti,ab,kw
(Word variations have been searched)
. #5 #1or#2or#3or#4
. #6 MeSH descriptor: [Motor Activity] this term only
. #7 MeSH descriptor: [Exercise] explode all trees
. #8 MeSH descriptor: [Sports] explode all trees
. #9 MeSH descriptor: [Sedentary Lifestyle] explode all trees
. #10 physical* activ*:ti,ab,kw (Word variations have been searched)
. #11 exercis* or sport*:ti,ab,kw (Word variations have been searched)
. #12 active near/2 (living or lifestyle):ti,ab,kw
(Word variations have been searched)
. #13 sedentary behavi?r:ti,ab,kw (Word variations have been searched)
. #14 (screen or sedentary or sitting or TV or television or computer or
PC or video games) near/2 time:ti,ab,kw (Word variations have been
searched)
. #15 #6or#7or#8or#9or#10or#11or#12or#13or#14
. #16 MeSH descriptor: [Accelerometry] explode all trees
. #17 acceleromet*:ti,ab,kw (Word variations have been searched)
. #18 actigraph*:ti,ab,kw (Word variations have been searched)
. #19 activity near/1 monitor*.:ti,ab,kw
(Word variations have been searched)
. #20 #16or#17or#18or#19
. #21 MeSH descriptor: [Overweight] explode all trees
. #22 overweight or obes*:ti,ab,kw (Word variations have been searched)
. #23 #21or#22
. #24 #5 and #15 and #20 and #23
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reliable and valid tool for assessing the quality of obser-
vational studies. It was considered initially for use in its
original form, which consists of over 30 items. The mod-
ifications to the original scale were made to focus quality
assessment on issues of particular importance to accel-
erometry measurement of physical activity. The modified
Tooth et al. tool has been used in several recent sys-
temic reviews of physical activity, all of which have re-
duced the number of items in the quality assessment to
8 to 17 items, which make up the quality score [24–28].
Results
Search results
The PRISMA flow diagram with the numbers of in-
cluded and excluded articles at each step of the review
process is provided in Fig 1. Tables 2 and 3 provide a
brief summary of all studies included in this systematic
review. Of 1503 papers identified in the initial review of
the five databases, 467 were selected for full-text screen-
ing and of these, 22 met the inclusion criteria. A further
four eligible studies were identified from searching
reference of included studies and of previous reviews,
giving a total of 26 studies which met the inclusion
criteria.
Studies characteristics
Of the 26 included studies: six studies involved children,
18 studies involved adolescents and two studies involved
both children and adolescents. Further, 22/26 compared
MVPA data in those with obesity with a non-obese
peers, while 13/26 studies also provided data on acceler-
ometer measured ST; 10/13 studies compared ST data
in those with obesity with non-obese peers.
Measurement protocol
The ActiGraph was the most common accelerometer
type used to measure habitual MVPA and/or ST, used in
20/26 studies, though with a variety of different Acti-
Graph models and approaches to data collection and re-
duction. Of the remaining six studies: three used the
Actical accelerometer [29–31]; two the Triaxial Research
Fig. 1 The PRISMA flow diagram with numbers of included and excluded articles at each step of the review process
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Tracker (RT3) accelerometer [32, 33]; and one the Acti-
watch accelerometer [34].
MVPA and ST in obese children
Eight eligible studies involved obese children, with a
total sample size of 2138 children (478 with obesity; 131
boys, 136 girls and 211 no sex specified). Two of the eli-
gible studies were clinical samples with study partici-
pants recruited from outpatient clinics. Eligible studies
were from different nations with one study from Asia
[35], three from Canada and USA [36–38] and four from
Europe [32, 39–41], with the study characteristics sum-
marized in Table 2. In four studies, MVPA data of boys
and girls were reported separately while in the other four
studies MVPA data were reported as mixed sex. 7/8 of
eligible studies reported mean daily time spent in MVPA
in minutes; in four studies mean time spent in MVPA
was < 60 min/day. Furthermore, in 2/7 of the eligible
studies, children with obesity reached or exceeded
60 min of MVPA per day [37, 38], while in one study
they came close to a mean of 60 min/day of MVPA [36].
In all cases time spent in MVPA in the children who
were obese was compared to the comparison group
(non-obese peers). In only one study was the mean time
spent in MVPA similar in both groups [37]; in three
studies, time spent in MVPA was significant lower in
children with obesity than in the comparison group [35,
36, 39], while in two studies time spent in MVPA of chil-
dren with obesity was lower than the comparison group
but differences were not significant [38, 40]. In the other
2 studies, time spent in MVPA of children with obesity
was different in terms of gender compared to the com-
parison group: Hussey et al. reported that mean MVPA
was significantly lower in boys with obesity but not in girls
[32]; while Vale et al. reported that mean time spent in
MVPA was significantly lower in girls with obesity but not
in boys [41] compared to the comparison groups.
With respect to ST, 4/8 eligible studies reported on
accelerometer-measured time spent in SB of children
with obesity with a total sample size of 536 children
(191 with obesity; 28 boys, 32 girls and 131 no sex speci-
fied). In one study, ST data of boys and girls was reported
separately while in other the data were reported as mixed
sex. Across all four eligible studies, mean time spent in SB
was > 70% of waking time [32, 35, 39, 40]. In 3/4 of the
studies ST was significantly higher in the obese than the
non-obese groups, although, in one study it was signifi-
cantly higher in boys with obesity but not in girls [32]. In
one study ST was similar in both groups [39].
MVPA and ST in obese adolescents
Twenty of the eligible studies involved adolescents, with
a total sample size of 12,601 adolescents (3045 with
obesity; 1615 boys, 1575 girls and 195 no sex specified).
Four of the eligible studies were clinical samples with
participants recruited from outpatient clinics. Eligible
studies were from different nations with one study from
Asia [42], 11 from Canada and the USA, and eight from
Europe, with the study characteristics summarized in
Table 3. In 12/20 studies, MVPA data of boys and girls
were reported separately; in 6/20 studies MVPA data
were reported as mixed sex, while the other two studies
involved only adolescent girls. All 20 eligible studies re-
ported mean daily time spent in MVPA in minutes and
in these studies it ranged from a low of 16 (SD 4) mi-
nutes/day [36] to a high of 140 (SD 47) minutes/day
[43]. In only 2/ 20 studies did daily time spent in MVPA
reach an average of at least 60 min [43, 44] in the ado-
lescents who were obese. A total of 16/20 eligible studies
compared time spent in MVPA of those with obesity
with a comparison group: in 3/16 time spent in MVPA
was similar between obese and non-obese groups, while
in 10/16 mean time spent in MVPA was significantly
lower in adolescents with obesity than in non-obese
peers.
In regard to time spent in SB, nine out of the 20 eligible
studies reported on accelerometer measured ST in adoles-
cents with obesity with a total sample size of 5484 adoles-
cents (1101 with obesity; 546 boys and 555 girls), as
summarised in Table 3. In 8/9 studies, ST data of boys
and girls were reported separately and 1/9 study involved
only adolescent girls. In 7/9 studies, mean daily ST was re-
ported in minutes and in these studies it ranged from a
low of 345 (SD 122) minutes/day [34] to a high of 731 (SD
110) minutes/day [30]. In 6/9 studies there was a compari-
son group; in 2/6 studies mean daily ST was similar in
obese and non-obese groups [42, 45]; in 2/6 studies ST
was significantly higher in those with obesity than in the
non-obese comparison groups [34, 46], while in the other
2/6 studies it was higher in the adolescents with obesity,
but not significantly so [47, 48].
A graphical synthesis of the mean differences and 95%
CI of time spent in MVPA by sex for both children and ad-
olescents with obesity and non-obese groups, is shown in
Fig. 2. A summary of the mean differences and 95% CI of
time spent in SB by sex for both children and adolescents
with obesity and non-obese groups, is shown in Fig. 3.
Study quality assessment
Study quality assessment summaries are given in
[Additional file 3]. One study scored 4/6 12 studies
scored 5/6 while 13 scored 6/6 on study quality.
Discussion
This systematic review provided clear evidence that chil-
dren and adolescents with obesity have lower than the
recommended levels of MVPA. In most of the eligible
studies, daily time spent in MVPA averaged less than the
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60 min/day recommended in many guidelines. When
comparing MVPA level between obese and non-obese
peers, the findings indicated that daily MVPA was lower
in children and adolescents with obesity.
In reviewing the methodology of the studies, it is note-
worthy that the precise accelerometer methodology was
often not stated clearly, or sometimes not stated at all,
in the eligible studies particularly with respect to the
cut-off used to define MVPA (Tables 2 and 3). However,
mean time spent in MVPA was broadly similar within
studies that employed comparable accelerometer
methods. For example, in the two eligible Actigraph
studies which used a cut-off of 2000 counts per minutes
(cpm) to define MVPA (Maggio et al. [40], age 4–
17 years old, and Ruiz et al. [46], age 12–17 year olds)
mean daily time spent in MVPA was 60 min/day in the
boys with obesity in the sample studied by Ruiz et al.
[46], and 60 min/day in the boys with obesity studied by
Maggio et al. [40]. Both of these studies might suggest
the tentative conclusion that time spent in MVPA is
relatively high in adolescents who are obese, possibly
suggesting that adolescence and/or obesity do not
present major barriers to MVPA. In contrast, three of
the eligible Actigraph studies used higher MVPA cut-
offs which ranged between 2912 cpm in 11–12 year olds:
Decelis et al. [47] and 3200 cpm Hughes et al. [39] and
Wafa et al. [35] in 8 and 9 year olds respectively. These
studies found that mean daily time spent in MVPA was
30 min in boys and 19 min in girls with obesity [47] and
a median of 16 min for both sexes combined in the
study by Hughes et al. [39] and 5 min/day in the study
by Wafa et al. [35]. The majority of children and adoles-
cents with obesity achieved means of < 30 min of daily
time spent in MVPA in studies with cut-offs of
≥2912 cpm [32, 38, 39, 43, 44].
Further, it should be noted that recommendations for
MVPA state that 60 min per day is a minimum every
day (e.g. usually operationalized as 7 days in a week)
Fig. 2 Forest plot of the comparison of moderate-to-vigorous intensity physical activity between children and adolescents with obesity and non-
obese participants by sex. SD: standard deviation; CI: 95% Confidence interval
Fig. 3 Forest plot of the comparison of sedentary time between children and adolescents with obesity and non-obese participants by sex. SD:
standard deviation; CI: 95% Confidence interval
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[49–51], but adherence to recommendations was never
operationalized in this way in any of the 26 eligible stud-
ies. We therefore used a mean or median daily MVPA of
60 min as a proxy for adherence, though this is conser-
vative because in many individuals where 60 min
MVPA/day was reached as an average, time spent in
MVPA would have fallen below 60 min/day on at least
one of the monitored days.
With respect to sedentary time, the present review
found that studies fairly consistently reported that chil-
dren and adolescents with obesity accumulated a high
amount of ST during their waking hours, ranging typic-
ally between 65 and 90% of their waking monitoring
time: 10 h was the mean daily ST in all 13/26 studies,
which reaches or exceeds typical Actigraph measured
levels of ST in North-American adults from surveys
such as NHANES. All eligible studies, which had com-
parison groups, found ST was fairly consistent with no
marked differences between obese and non-obese peers.
In the present systematic review, the level of hetero-
geneity between eligible studies made it impossible to
combine data in a formal meta-analysis. The heterogen-
eity noted was due to differences in the location of the
studies, differences in the way obesity was defined (dif-
ferent BMI cut-off points and different reference data),
or differences in accelerometer models and method-
ology. Therefore, we narratively synthesized the differ-
ences in the time spent in MVPA and ST between obese
and control groups by age and sex. Additionally, future
research would benefit from an attempt to obtain the
original study participant data and to reanalyse that with
a common methodology, though this was beyond the
scope of the present study.
Comparisons with other studies
We believe that the present study is the first systematic
review to ask whether or not levels of accelerometer
measured MVPA are adequate in children and adoles-
cents with obesity, and whether time spent in MVPA
and ST differed between obese and comparison groups
based on accelerometer data. There are therefore no dir-
ectly comparable studies. However, our findings are con-
sistent with some studies on the correlates and
determinants of objectively MVPA [52, 53], and consist-
ent with a growing belief that obesity is associated with
reduced MVPA and that low MVPA could be both a
cause of obesity and a consequence of obesity, i.e., “bi-
directional causation” [20, 54, 55].
Review and evidence strengths and weaknesses
The evidence considered by our review had a number of
strengths. Firstly, it investigated the accelerometer-
measured time spent in MVPA and ST of children and
adolescents with obesity, with clear definitions of obesity
so that samples included in the review were not contam-
inated by the inclusion of overweight but non-obese in-
dividuals. Secondly, there are several methodological
strengths to this study. Studies were identified from an
extensive search of the published literature conducted in
a range of databases, over the last 15 years, covering the
time when accelerometers started to become available
and popular in PA research and, more recently, seden-
tary behavior research. The broad definition of search
terms applied across multiple databases enabled the
searching and identification across many potential stud-
ies with no limitations on place of publication, sample
size or country of origin. Restricting eligibility to studies
using accelerometry was important in increasing confi-
dence in the measurement of MVPA [19, 56–58]. The
included studies were in general rated as being of high
or very high methodological quality with respect to their
accelerometry methods. Also, in some cases the eligible
studies were based on large nationally representative
samples or surveys another strength in terms of
generalizability.
There were some sources of weakness in our system-
atic review. Firstly, since studies had to be published in
peer-reviewed journals in English, this may have ex-
cluded some relevant evidence. The generalisability of
review results is subject to certain limitations; for in-
stance, eligible studies in our systematic review were
from high-income nations, and we lacked data from
low-middle income countries. Most of the included
studies were based on relatively small samples of obese
children and adolescents with a total (n = 14,739 partici-
pants; n = 3523 with obesity) and their power to estimate
habitual MVPA might have been limited, and thus the
extent to which the results observed are generalizable to
the general obese paediatric population is unclear. The
method of quality assessment in our review, in which
the original 15 items scale has been collapsed to 6 items,
has been used in several accelerometry systematic re-
views [24–28]. However, the process of collapsing 15
items to a six-item might have reduced the possibility of
identifying differences in quality between studies.
Eligible studies generally obtained MVPA and ST data
using the ActiGraph accelerometer, but methods used
varied between studies. Methodological differences in-
clude: the definition of epoch, the number of hours and
days of data constituting a valid/acceptable data set,
MVPA and ST cut-points, and the choice of non-wear
criteria. These methodological variation tends to pro-
duce meaningful differences in MVPA and ST estimates
between studies [16] and also make it difficult to com-
pare across studies. However, while there were multiple
differences between studies in accelerometry method-
ology (e.g. in epochs, cut-points, handling of non-wear
time, duration of accelerometry monitoring), in all cases
Elmesmari et al. BMC Pediatrics  (2018) 18:106 Page 19 of 22
the methods were the same within studies between the
obese and non-obese comparison groups, so these meth-
odological differences probably had limited effect on the
ability of studies to identify differences in MVPA and ST
between the obese and non-obese. Finally, the validity of
accelerometry (in particular hip-worn accelerometry, the
method in almost all eligible studies) to determine ST is
less well established than the validity of this placement
for measurement of MVPA [59]. Hip-worn accelerome-
ters are not designed to measure posture, and devices
such as inclinometers may provide improved measure-
ment. Accelerometers are used widely to measure ST
though, and there is some evidence of validity for group-
comparisons as here (obese vs non-obese comparisons)
[19, 16].
Conclusions
In summary, the data presented in our review demon-
strated that a high percentage of obese children and ado-
lescents did not achieve the minimum amount of
60 min per day MVPA that is recommended in guide-
lines and tended to spend what appeared to be the vast
majority of their waking hours sedentary. Children and
adolescents with obesity were generally slightly less
physically active and slightly more sedentary compared
to comparison groups, though the present review cannot
test whether they were less active or more sedentary be-
fore becoming obese.
Given the many and varied health and non-health ben-
efits of MVPA in children and youth [60, 61], and emer-
ging evidence that ST influences health outcomes in
children and adolescents [62, 63] the present review
highlights the need to focus on increasing MVPA and
reducing ST among children and adolescents with obes-
ity, and the importance of raising these issues in clinical
settings as part of treatment for obesity. Treatment of
childhood and adolescent obesity should clearly involve
a focus on increasing MVPA and reducing ST as recom-
mended in multiple evidence based treatment and pre-
vention guidelines published in recent years.
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